ArticleInfectious disorders drug targets2022

A Clinically Validated, Broadly Active, Oral Viral Superinfection Therapy Could Mitigate Symptoms in Early-stage COVID-19 Patients.

Tibor Bakacs et al.PubMed ↗Publisher ↗

No numbers read from the abstract.